Skip to main content
Fig. 1 | Diabetology & Metabolic Syndrome

Fig. 1

From: Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21–AMPK pathway in mice fed a high fat diet

Fig. 1

Effects of EGCG on body mass, biochemical levels in HFD-fed C57BL/6 mice. A Experimental flow chart; B effects of EGCG on body weight; C effects of EGCG on glucose levels; D, E effects of EGCG on serum TG and TC, F, G effects of EGCG on TG and TC in liver tissue, H, I serum ALT and AST levels, J IPGTT-AUC (area under the curve); K HE (× 200) of livers, L oil red O staining (× 200) of livers. #p < 0.05, ##p < 0.01, ###p < 0.001, ####p < 0.0001 vs CON; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 vs HFD (the CON, n = 10), HFD (n = 12) and HFD + EGCG (n = 12)

Back to article page